Because of their short stature, patients with dwarfism often face a lot of pressure and distress in their image and thoughts. For this reason, the medical community has been studying to solve the mystery of dwarfism and change them to the greatest extent. dwarf status. Based on the new Nobel Prize-winning theory of biomedicine: "NEI Biological Homeostasis Regulation Technology" successfully deciphered the code of dwarfism. Based on the new medical theory of biomedical scientists Vishaus and Forhard, children's medicine in four countries: China, Japan, the United States, and South Korea The center has launched a clinical trial in conjunction with the "BCT biological intervention technology" that has been researched with great concentration. Based on the "BCT Biological Intervention Technology", the short stature expert team of Shanghai Hongci Children's Hospital has successfully deciphered the code of dwarfism. Based on more than 300 diseases that cause short stature, it has explored and developed "NEI biological homeostasis regulation" that is more suitable for modern people to increase their height. technology". Data show that in the clinical application of this technology, 97.2% of children with dwarfism have returned to normal height. Reviews after treatment showed that there were no side effects and no case of premature bone closure. Principle of "NEI Biological Homeostasis Regulation Technology": Traditional Chinese and Western medicine + modern high-end biomedicine NEI Biological Homeostasis Regulation Technology stimulates the regrowth of osteoarticular cartilage and epiphyseal cartilage by activating the sensitivity of GH to the IGF-1 gene receptor. At the same time, it promotes protein synthesis, enhances the intake and utilization of important elements such as sodium, potassium, calcium, phosphorus, and sulfur, promotes human metabolism, and allows the body to grow naturally. At the same time, this technology combines the essence of traditional Chinese medicine, Western medicine and modern high-end biomedicine, and integrates eight major technologies, including accurate bone age assessment technology, rapid hormone detection technology, traditional Chinese medicine conditioning, genetic immune activation, aromatase inhibitors, and GABA supplementation. The technical characteristics are the most comprehensive and systematic technology developed by the medical community so far, and it has been clinically applied around the world. "NEI biological homeostasis regulation technology" heightening advantages: safe, efficient, painless 1. Safety. NEI biological homeostasis adjustment technology is non-invasive, safe, simple in clinical operation, and has long-lasting efficacy; it also overcomes the disadvantages of traditional treatments such as high pain and difficulty in acceptance. 2. Efficient. NEI biological homeostasis regulation technology combines and integrates multiple effects, including meridian science, yin and yang balance theory, neural cross-over theory and holographic effects, and has an irreplaceable clinical effect in the treatment of dwarfism. 3. No pain. NEI biological homeostasis adjustment technology is non-invasive, causes no damage to the body, and causes no pain to the patient during the treatment process, so it is easily accepted by patients and has no side effects or long-term sequelae. "NEI Biological Stabilization Technology": Nearly 10,000 children with dwarfism have realized their dream of rapid growth. After the successful clinical application of BCT biological intervention technology in Japan and South Korea, the Chinese health and medical department began to pay attention to it. Through cooperation from many aspects, "NEI Biological Stabilization Technology" "Adjustment Technology" was successfully developed in Shanghai Hongci Children's Hospital, a national key hospital specializing in children's growth and development. Since its clinical application, it has helped nearly 10,000 children with dwarfism realize their dream of rapid growth. The hospital has continuously won the "National Key Children's Growth and Development" award. "Specialized Hospital", "China's Authoritative Diagnosis and Treatment Demonstration Base for Short Stature" and other honorary titles. Shanghai Hongci Children's Hospital attracts and builds a team of medical experts with rich clinical experience to lead the direction of modern medical care. This is the original intention of Shanghai Hongci Children's Hospital. It is also a strong guarantee for Hongci to become a brand specialist hospital in Shanghai. Starting from itself, Hongci continuously improves medical research and creates conditions, attracting a large number of medical experts with the highest level in the country. The advent of MOGT biological targeted repair technology has effectively solved the problem that traditional medicine cannot effectively treat neurological diseases, and opened a new page in history to achieve the goal of human health. At the same time, it was announced that various neurological diseases such as ADHD, tics, autism, enuresis, and other syndromes (learning difficulties, brain hypoplasia, lead poisoning, attention disorders) will be treated more effectively. At present, this technology has successfully applied for a number of international invention patents including PCT, China, the United States, Japan, and the European Union, bringing an epoch-making leap to the diagnosis and treatment of neurological diseases and pointing out the direction of clinical research development. Since its establishment, Shanghai Hongci Children's Hospital has always paid attention to new medical developments at home and abroad, and has taken the lead in introducing a batch of high-tech, sophisticated medical equipment and technologies from the United States, Sweden, Australia and other countries. With forward-looking and innovative thinking, the center introduces internationally advanced medical management models and hires authoritative pediatric experts to lead a high-level technical team.
Relying on their excellent professional skills in pediatric neurological diseases and many years of rich clinical diagnosis and treatment experience, hospital experts have directly applied the latest international research results into clinical diagnosis and treatment, continuously solving bottlenecks in the field of ADHD and tics, with remarkable results.